Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2023 | Optimizing treatment protocols for young adult patients with cancer

Vanessa McLelland • 9 Oct 2023
BOPA 2023
General
UKALL 2011

Vanessa McLelland, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK, discusses benefits of administering pediatric treatment plans to young adult patients. As demonstrated in the Phase III UKALL 2011 trial (EudraCT 2010-020923-22), young adult patients fared better when given pediatric protocols. Recruitment of young adult patients in this setting additionally benefits trial organizers, where more reliable data can be obtained upon enrolment of young adult patients. This interview took place at the 26th Annual British Oncology Pharmacy Association (BOPA) Symposium in Newport, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vanessa McLelland

0:39
Challenges of treating young adult cancer patients
Vanessa McLelland • 4 Oct 2022
0:50
Considerations for researching pharmacological management of pediatric cancer
Vanessa McLelland • 4 Oct 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals